Recombinant Human CNTF Protein，His

CNTF (Ciliary Neurotrophic Factor) is a member of the interleukin-6 family of cytokines and plays a crucial role in the survival, differentiation, and maintenance of various neuronal populations in the central and peripheral nervous systems. Given its neuroprotective properties, CNTF has garnered significant attention for its potential therapeutic applications in neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS). The recombinant form of CNTF has been developed to explore its biological functions and therapeutic efficacy. Early studies demonstrated that CNTF can promote neuronal survival and regeneration, making it a candidate for treating conditions associated with neuronal damage. However, the clinical application of CNTF has faced challenges, such as achieving adequate delivery to target cells and mitigating side effects. Recent advances in biotechnology have facilitated the production of recombinant CNTF with enhanced stability and bioactivity, leading to a better understanding of its mechanisms of action. Research has also focused on optimizing CNTF formulations and delivery methods to improve its therapeutic index. The ongoing investigations into CNTF’s roles in neural repair and its impact on various neurological disorders underscore its potential as a valuable tool in regenerative medicine and highlight the importance of continued research in unlocking its full therapeutic capabilities.